These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DNA methylation of microRNA genes in multiple myeloma. Wong KY; Huang X; Chim CS Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154 [TBL] [Abstract][Full Text] [Related]
4. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles. Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352 [TBL] [Abstract][Full Text] [Related]
5. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Gutiérrez NC; Sarasquete ME; Misiewicz-Krzeminska I; Delgado M; De Las Rivas J; Ticona FV; Fermiñán E; Martín-Jiménez P; Chillón C; Risueño A; Hernández JM; García-Sanz R; González M; San Miguel JF Leukemia; 2010 Mar; 24(3):629-37. PubMed ID: 20054351 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: role in cardiovascular biology and disease. Zhang C Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as a new potential therapeutic opportunity in gastrointestinal cancer. Boni V; Bandres E; Zarate R; Colucci G; Maiello E; Garcia-Foncillas J Oncology; 2009; 77 Suppl 1():75-89. PubMed ID: 20130435 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: novel regulators in the hallmarks of human cancer. Ruan K; Fang X; Ouyang G Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788 [TBL] [Abstract][Full Text] [Related]
9. Epigenetics in Multiple Myeloma. Glavey SV; Manier S; Sacco A; Salem K; Kawano Y; Bouyssou J; Ghobrial IM; Roccaro AM Cancer Treat Res; 2016; 169():35-49. PubMed ID: 27696257 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches. Rossi M; Amodio N; Di Martino MT; Tagliaferri P; Tassone P; Cho WC Curr Pharm Biotechnol; 2014; 15(5):459-67. PubMed ID: 24846067 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and their emerging roles in immunology. Pauley KM; Chan EK Ann N Y Acad Sci; 2008 Nov; 1143():226-39. PubMed ID: 19076353 [TBL] [Abstract][Full Text] [Related]
12. The potential role of miRNAs in multiple myeloma therapy. Caracciolo D; Montesano M; Altomare E; Scionti F; Di Martino MT; Tagliaferri P; Tassone P Expert Rev Hematol; 2018 Oct; 11(10):793-803. PubMed ID: 30148649 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in the pathobiology of multiple myeloma. Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Yang BF; Lu YJ; Wang ZG Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):951-60. PubMed ID: 19566826 [TBL] [Abstract][Full Text] [Related]
15. The role of microRNA in human leukemia: a review. Yendamuri S; Calin GA Leukemia; 2009 Jul; 23(7):1257-63. PubMed ID: 19148134 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA: important player in the pathobiology of multiple myeloma. Bi C; Chng WJ Biomed Res Int; 2014; 2014():521586. PubMed ID: 24991558 [TBL] [Abstract][Full Text] [Related]